Onward Therapeutics

Onward Therapeutics is a clinical-stage oncology company headquartered in Taipei, Taiwan, developing treatments for hard-to-treat and resistant cancers, with hubs in Taipei, Lausanne and Paris. Its pipeline pairs clinical-stage assets, the tetravalent bispecific antibody OT-A201 and the off-the-shelf allogeneic NK cell therapy OT-C001, with two early-stage discovery programs. Founded in 2019 and originally based in Switzerland, the company moved its global headquarters to Taiwan through a share exchange completed in October 2025.

  • Series B
  • Biotechnology
  • Clinical Trials
  • Healthtech
  • Pharmaceuticals
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 18, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 18, 2026

    TWD 900M

    Series B

    • Everbright Biofund
    • Chlitina (克丽缇娜)
    • CDIB Capital Healthcare Ventures
    • Beiley Biofund
    • Test Rite International Co., Ltd.
    • Grand Fortune Venture Capital
    • Hercules Bioventure Partners
    • MitoBitTech Venture
    • Top Taiwan Venture Capital

    Article coming soon.

Pricing

Research Onward Therapeutics — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Onward Therapeutics is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational